Skip to content
Parker Institute for Cancer Immunotherapy
Search
Search Close

University of California, Los Angeles

UCLA is developing breakthrough research that broadens immunotherapy’s benefits to help more patients

The T-cell—the all-powerful immune system player—is at the core of groundbreaking research at the UCLA Jonsson Comprehensive Cancer Center. Researchers collaborate across disciplines such as oncology, immunology and virology to genetically engineer T-cells and translate their discoveries into treatment strategies for a wide range of cancer types. Working with the PICI network, UCLA investigators are furthering research to learn more about the immune system’s role in the fight against cancer.

Antoni Ribas, MD, PhD | Director